What are the recent financial highlights of METROPOLIS HEALTHCARE LTD?

METROPOLIS HEALTHCARE LTD recently reported a total revenue of ₹1,316.91 Cr and a net profit margin of 11.56%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of METROPOLIS HEALTHCARE LTD?

METROPOLIS HEALTHCARE LTD offers a dividend yield of 0.2%, with a dividend rate of ₹4.0 per share.

What are the key financial metrics of METROPOLIS HEALTHCARE LTD?

Key financial metrics include a trailing P/E ratio of 49.599934, forward P/E of 34.936092, book value of ₹231.094, price-to-book ratio of 6.35737, and a market capitalization of ₹76.10 billion.

What does METROPOLIS HEALTHCARE LTD do?

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Metropolis

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Metropolis

Latest updates related to Metropolis

Sr No.	Title	Sentiment
1	JHS FFA, Barnyard Buddies introduce Maple Grove students to different ag aspects Metropolis Planet	🔄
2	Massac bumps off Murphy to reach regional finals Metropolis Planet	🔄
3	Midcap Picks With Anil Singhvi: Indian Hume Pipe, Metropolis and CARE Ratings - 3 very buzzing counters Zee Business	🔄
4	Stock Radar: Tata Motors, Syngene, Metropolis, Bharat Electronics, Lupin, Isgec Heavy, Suraksha... Moneycontrol	🔄
5	Ryan Decker Creates an Immersive Neo-Medieval Installation at Superhouse Metropolis Magazine	🔄
6	Overall Best Farmer in Accra Metropolis honoured with Polytank, fertilizers, insecticides, seeds Myjoyonline	🔄
7	Stock Radar: Tata Motors, Syngene, Metropolis, Bharat Electronics, Lupin, Isgec Heavy, Suraksha... Moneycontrol	🔄
8	Metropolis Healthcare Aims To Boost North India Presence With Agra Diagnostic Chain Acquisition NDTV Profit	🔄
9	Metropolis strengthens UP presence with acquisition of Scientific Pathology Business Standard	🔄
10	'The real competition isn’t bigger players...': Metropolis Healthcare's Ameera Shah on the unorganised market Business Today	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

SHRIRAMFIN HONASA RACLGEAR ARSHIYA MUTHOOTMF TVSELECT SUNTECK JYOTICNC GOENKA GABRIEL